According to IPA disease comparison analysis, C498 alleviated a variety of inflammatory diseases including shock response, systemic inflammatory response, lung injury, rheumatic diseases, acute colitis, inflammatory bowel disease, and inflammation of respiratory system, not to mention the pivotal roles of JAK/STAT and NFκB signaling pathways in these inflammatory diseases. This evidence concerns the gene NFKB1 and rheumatic disorder.